Promosome LLC and Lonza Biologics Announce Strategic Partnership

Strategic Insights -

Promosome LLC, a biotechnology company, has signed a non-exclusive technology evaluation contract with Lonza Biologics, a leader in contract manufacturing and enabling technologies for the pharmaceutical and biopharmaceutical industry. Under this agreement, Lonza will evaluate Promosome's Translation Enhancing Elements (TEEs) in combination with its proprietary GS(tm) expression technology. This partnership further demonstrates the growing interest in the commercial potential of Promosome's translation enhancing technology.

Key Takeaways:

  • Promosome LLC has signed a non-exclusive technology evaluation contract with Lonza Biologics, a recognized leader in contract manufacturing and enabling technologies.
  • The agreement will have Lonza evaluate Promosome's Translation Enhancing Elements (TEEs) in combination with its proprietary GS(tm) expression technology.
  • TEEs are synthetic messenger RNA (mRNA) sequences that can be used to enhance protein expression in various eukaryotic cells.
  • The partnership is expected to be highly complementary to Lonza's proprietary GS(tm) expression technology.
  • The GS(tm) expression technology is a key part of Lonza's capabilities in large and small molecules, peptides, amino acids, and niche bioproducts.
  • Promosome's chief executive, John Manzello, expressed excitement about the collaboration with Lonza, citing the organization's reputation as a leader in the biopharmaceutical manufacturing field.
  • Promosome was founded by the Life Sciences commercialization team of William J. Gedale and John R. Costantino, and has a Research Funding and Option Agreement with TSRI (The Scripps Research Institute).
  • Promosome has world-wide exclusive license and sub-license rights to the TEE Technology.
  • Lonza is headquartered in Basel, Switzerland, and had sales of CHF 2.87 billion in 2007.

Statistics:

  • In 2007, Lonza had sales of CHF 2.87 billion.
  • Promosome LLC is a New York City-based biotechnology company founded by the highly regarded Life Sciences commercialization team of William J. Gedale and John R. Costantino.
  • TSRI (The Scripps Research Institute) is the institution where Nobel Laureates Dr. Gerald M. Edelman, Dr. Vincent P. Mauro, and others are based.

Sources:

  • GlobeNewswire (via COMTEX)
  • Promosome LLC official press release
  • Lonza Biologics official website (www.lonza.com)